CNPD3 Seminar Series Invites Dr. Timothy Newhouse from Yale University
Synthesis of Neuroactive Terpenoids Using Chemical and Computational Strategies…
Synthesis of Neuroactive Terpenoids Using Chemical and Computational Strategies…
Dr. Wang is a professor in the Department of Chemistry and Biochemistry at the University of Maryland. “The Wang Lab is working at the interface of chemistry, biology, and immunology with a…
Daniel Schultz, a second year Ph.D. student of Medicinal Chemistry, won the UF College of Pharmacy’s 32nd Annual Research Showcase Oral Competition in the Junior Division. The showcase took place on February 11th, 2019 and the winners were announced the following day. Schultz presented the research title Structure-based Drug Design…
Take a look at the scheduled seminar speakers and topics. We look forward to seeing you there.
Ramon Gonzalez, Ph.D., professor of chemical and biomolecular engineering at the University of South Florida and the founding director of the Advanced Biomanufacturing Initiative (iBIO).
The $400,000 grant will support development of a small molecule protein degrader for cancer treatment.
The grant will bolster research on Mitragyna speciosia, or kratom, and its potential to treat opioid misuse and physical dependence.
Dr. Nathanael Gray, Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School will present “Targeted Protein Degradation as a New Anti-Cancer Drug Strategy” on December 7th.
UF researchers discovered their compounds induced rapid iron starvation through a series of experiments using novel compounds known as halogenated phenazines, or HPs.